A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy ca. 2025 from @NEJM #Nephpearls #KidneyWk #VisualAbstract by @NephroSeeker @NephJC 👉🏼 https://t.co/XlG8LwsUmy

#Empagliflozin and #Ultrafiltration Volume in Patients Undergoing #PeritonealDialysis #VisualAbstract by @elbaonelida https://t.co/GajU10KsFy

1/ After many years of editing, I'm thrilled to release the 5th edition of the Visual Abstract Primer! Notably, its a lot short (11 pages, down from 56!) Full download here: https://t.co/GaDTPzhdw7 Summary below... #VisualAbstract

Sibeprenlimab in IgA Nephropathy: Interim Analysis of a Phase 3 Trial ca. 2025 from @NEJM #Nephpearls #KidneyWk #VisualAbstract by @NephroSeeker @NephJC 👉🏼 https://t.co/6GICMthDNA

Evaluating #Sibeprenlimab in #IgA Nephropathy - Rationale and Baseline Data from the #VISIONARY Trial #VisualAbstract by @nephromythri https://t.co/aQk3TGahLt

Still very cool to sit in grand rounds and see a #VisualAbstract after #VisualAbstract make it into the slide deck. Hard to underestimate how much good science AND good design helps dissemination. #meded

The #VisualAbstract has come a long way in 7 years: ✅ 5 RCTs demonstrating reproducible ⬆️dissemination ✅ Adoption by >100 journals & orgs ✅ open source primer approaching 5th Ed. Yet, there is so much more it can do to improve patient care: https://t.co/OvPI2CveGM

💊 Do we really need to add PPI for all the patients who are on corticosteroids? Or ☄️We are just adding to the cost and pill burden to the pts 🔥 https://t.co/yJC5d9Yfkr #VisualAbstract by @SuchitaSata

Predicting #Simultaneous #Heart #Kidney Allocation and Posttransplant Adverse Kidney Outcomes #VisualAbstract by @krithicism https://t.co/s6aO5eJUSx @tanrioverbekir

#Delphi Consensus on Surrogate Endpoints in #C3G and Primary #ICMPGN #VisualAbstract by @jmteakell https://t.co/n2PXU1q1Aq

#LiverCyst #Infection Outcomes in Patients With Autosomal Dominant Polycystic Kidney Disease #ADPKD #VisualAbstract by @KajareeG https://t.co/a7V73x3pua

Great to make the holiday list! Indeed, a lot we can do in 2024 to better utilize the #VisualAbstract to improve patient communication, clinical training, trial recruitment and guideline adherance. https://t.co/OvPI2CvMwk

Early #GoalDirected Hemostatic Therapy for Severe Acute Bleeding Management in the #ICU https://t.co/4gm8drClZJ #Transfusion #TransfusionMedicine #visualabstract #POCT

#MassSpectrometry of Minimal Change Disease and Focal Segmental Glomerulosclerosis #MCD #FSGS #VisualAbstract by @sophia_kidney https://t.co/QOxgbBYBw2

Effects of Once-Weekly 💉 Semaglutide #Nephpearls #Cardiorenal #VisualAbstract by @AnjanaGopal9 @kidney_boy @brian_rifkin FLOW 👉 https://t.co/DwXn853t6k SUSTAIN 6 👉 https://t.co/HzvdjLJVfg SUSTAIN 6 Posthoc 👉 https://t.co/4F6VABgwgd Nice write up here by @kidney_boy 👉

Testing for the Best Biomarker 🧪 in IgA Nephropathy #IgAN ca. 2025 from @asnpublications #Nephpearls Editorial by @kidneybiz 👉 https://t.co/rddl7X2fPN #VisualAbstract by @hellokidneyMD 👉 https://t.co/KMn7q8rjYc

Longitudinal Trajectories of Chronic #Kidney Disease-Associated #Pruritus #VisualAbstract by @KajareeG https://t.co/Y4yxGnaOa1

Outcomes of Initiating Peritoneal Dialysis versus Hemodialysis in Severe, Symptomatic Kidney Failure ca. 2025 from @asnpublications #Nephpearls #BestofKidney360 #KidneyWk #VisualAbstract by @Vernisartan 👉 https://t.co/AgiZAjhuzL

#VisualAbstract A Comparison of Decompression Size and Craniectomy Speed of Reverse Question Mark Versus Retroauricular Incisions for Decompressive Hemicraniectomy: A Cadaver Study https://t.co/GKNQ3OLHIw by McIntyre et al at Oregon Health and Science University @CNS_Update